Description: Imagin Medical is developing imaging solutions for the early detection of cancer and improved visualization through the use of endoscopes. The Company believes it will radically improve the way physicians detect cancer and view the surgical field. Imagin's initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a greater than 50% recurrence rate.
Home Page: imaginmedical.com
890 West Pender Street
Vancouver,
BC
V6C 1L9
Canada
Phone:
833 246 2446
Officers
| Name | Title |
|---|---|
| Mr. Edward James Hutchens | CEO, Pres & Director |
| Mr. John F. Vacha CPA | CFO & Corp. Sec. |
| Mr. Michael G. Vergano | Director of Operations |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 9.052 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | September |
| Full Time Employees: | 0 |